Въпреки това няма показания за по- висок антигенен потенциал на Xeomin в сравнение с Botox.
At present there are three ongoing clinical studies with Xeomin (all of which have a placebo- controlled single injection main period and subsequent extension periods, in which only Xeomin is administered).